Neoadjuvant chemotherapy followed by D2 gastrectomy and esophagojejunal Roux‑en‑Y anastomosis in gastric small cell carcinoma: A case report

Xin,Kai; Wei,Jia; Wang,Hao; Guan,Wenxian; Liu,Baorui

doi:10.3892/ol.2014.2557

Neoadjuvant chemotherapy followed by D2 gastrectomy and esophagojejunal Roux‑en‑Y anastomosis in gastric small cell carcinoma: A case report

Authors:
- Kai Xin
- Jia Wei
- Hao Wang
- Wenxian Guan
- Baorui Liu
View Affiliations

Affiliations: The Comprehensive Cancer Center of Nanjing Drum‑Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China, Department of General Surgery, Nanjing Drum‑Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, P.R. China
Published online on: September 24, 2014 https://doi.org/10.3892/ol.2014.2557
Pages: 2549-2552

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A 60‑year‑old male was referred to Nanjing Drum‑Tower Hospital (Nanjing, Jiangsu, China) due to the presence of gastric carcinoma. A biopsy was performed under an electronic gastroscope and the pathological analysis resulted in the diagnosis of gastric small cell carcinoma (GSCC). The mass had invaded the liver and the pancreas according to an enhanced computed tomography scan, thus current surgical methods were considered to be of high risk and highly challenging. Following four cycles of neoadjuvant chemotherapy with irinotecan (200 mg, days 1, 21, 41 and 61) and oxaliplatin (120 mg, days, 1, 21, 41 and 61) the patient underwent a D2 gastrectomy and an esophagojejunal Roux‑en‑Y anastomosis, followed by adjuvant chemotherapy. The patient experienced survival without progression in the 8‑month follow‑up. To the best of our knowledge, this is one of few cases of GSCC treated with the combination of neoadjuvant chemotherapy, surgery and adjuvant chemotherapy.

View Figures

View References

1	van der Heijden HF and Heijdra YF: Extrapulmonary small cell carcinoma. South Med J. 98:345–349. 2005.
2	Tanemura H, Ohshita H, Kanno A, et al: A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis. Int J Clin Oncol. 7:128–132. 2002.
3	Frances N, Zeichner SB, Francavilla M and Cusnir M: Gastric small-cell carcinoma found on esophagogastroduodenoscopy: a case report and literature review. Case Rep Oncol Med. 475961:2013.
4	Remick SC and Ruckdeschel JC: Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome. Med Pediatr Oncol. 20:89–99. 1992.
5	Funahashi H, Miyai H, Wakasugi T, et al: Successful combination chemotherapy with irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma: report of a case. World J Surg Oncol. 11:2632013.
6	Aoyama T, Yoshikawa T, Shirai J, et al: A case of gastric small cell carcinoma with metastatic liver tumors responding to surgery and chemotherapy. Gan To Kagaku Ryoho. 39:1889–1891. 2012.(In Japanese).
7	Takaku H, Oka K, Naoi Y, Santoh N, Setsu Y and Mori N: Primary advanced gastric small cell carcinoma: a case report and review of the literature. Am J Gastroenterol. 94:1402–1404. 1999.
8	Arai K and Matsuda M: Gastric small-cell carcinoma in Japan: a case report and review of the literature. Am J Clin Oncol. 21:458–461. 1998.
9	O’Byrne KJ, Cherukuri AK, Khan MI, et al: Extrapulmonary small cell gastric carcinoma. A case report and review of the literature. Acta Oncol. 36:78–80. 1997.
10	Brenner B, Tang LH, Klimstra DS and Kelsen DP: Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 22:2730–2739. 2004.
11	Bosman FT, Carneiro F and Hruban RH: WHO classification of tumours of the digestive system. 3. 4th edition. IARC Press; Lyon: 2010
12	Klimstra DS, Modlin IR, Coppola D, et al: The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 39:707–712. 2010.
13	Tan EH and Tan CH: Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol. 2:28–43. 2011.
14	Kim JH, Lee SH, Park J, et al: Extrapulmonary small-cell carcinoma: a single-institution experience. Jpn J Clin Oncol. 34:250–254. 2004.
15	Huang S, Zheng ZX, Xu Q and Yuan XH: The diagnosis, treatment and prognosis evaluation of gastric small cell carcinoma: analysis of 41 cases. Zhonghua Wai Ke Za Zhi. 51:225–229. 2013.(In Chinese).
16	Kusayanagi S, Konishi K, Miyasaka N, et al: Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol. 18:743–747. 2003.
17	Matsusaka T, Watanabe H and Enjoji M: Oat-cell carcinoma of the stomach. Fukuoka Igaku Zasshi. 67:65–73. 1976.
18	Matsui K, Kitagawa M, Miwa A, Kuroda Y and Tsuji M: Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol. 86:1167–1175. 1991.
19	Shao LH, Hua MR, Jun C, et al: Analysis of clinical pathology and therapy in gastric small cell carcinomas. J Pract Med. 23:2543–3544. 2007.
20	Ping Z, Ling CT and Jing L: Two case reports of gastric small cell carcinoma and literature review. Chin J Clin Oncol Rehabil. 8:782001.
21	Li X, Liao Z and Guo Y: Small cell carcinoma of the stomach with liver and bone metastasis: a case report. J Modern Oncol. 19:1421–1422. 2011.
22	Huang S, Zheng ZX, Xu Q and Yuan XH: The diagnosis, treatment and prognosis evaluation of gastric small cell carcinoma: analysis of 41 cases. Zhonghua Wai Ke Za Zhi. 51:225–229. 2013.(In Chinese).
23	Kudoh S, Fujiwara Y, Takada Y, et al: Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. J Clin Oncol. 16:1068–1074. 1998.
24	Boku N, Ohtsu A, Shimada Y, et al: Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol. 17:319–323. 1999.
25	Noda K, Nishiwaki Y, Kawahara M, et al; Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med. 346:85–91. 2002.